Results 241 to 250 of about 4,166,301 (304)

Multi-Label Classification of Adverse Drug Reactions Using a Hybrid Approach Integrating Support Vector Machine, Random Forest and Extreme Gradient Boosting. [PDF]

Pharmaceuticals (Basel)
Cucos AM, Gáll Z, Iantovics LB.
europepmc   +1 more source

Versatile Co‐Engineering of Immunogenic Cell Death‐Primed Dead Tumor Cell Bodies With Tumor‐Activated MnO2 for cGAS‐STING‐Potentiated Personalized Immunotherapy

Advanced Science, EarlyView.
DTBEI@CS@MnO2, fabricated via modular electrostatic co‐engineering and photothermal/photodynamic immunogenic cell death, specifically responds to the acidic and GSH‐rich tumor microenvironment. This triggers the release of DTBEI that provides tumor antigens, DNA, and DAMPs, as well as the generation of Mn2+, thereby synergistically potentiating cGAS ...
Bolun Xu, Xuan Lu, Yuquan Wang, Haihua Ji, Ying Zhang, Yiqun Wan, Hao Wan   +6 more
wiley   +1 more source

Association of high risk of liver fibrosis in patients with serious outcomes of adverse drug reactions. [PDF]

Eur J Clin Pharmacol
Henze J, Dormann H, Schneider CV, Meeßen C, Knüppel-Ruppert A, Kriegisch-Stumpf A, Schwab M, Stingl JC, Just KS.   +8 more
europepmc   +1 more source

Tailored Covalent Organic Frameworks Enable the Encapsulation of Living Cells to Produce Rare Ginsenoside

Advanced Science, EarlyView.
This work reports the in situ fabrication of Escherichia coli@covalent organic frameworks (E. coli@COFs) in phosphate‐buffered saline. The COFs form an exoskeleton on E. coli, protecting intracellular β‐glucosidase (Ssbgl) while enhancing mass transfer.
Fengmei Liu, Shan Zhang, Shanrong Wei, Ziye Xing, Hongming He, Xiao Liang, Quanshun Li   +6 more
wiley   +1 more source

When Side Effects Become Therapies: A Mechanistic Taxonomy of Adverse Drug Reactions as Translational Signals for Drug Repositioning. [PDF]

Fundam Clin Pharmacol
Emanuele E, Minoretti P, Ballerio M, Santos-Lozano A, Lista S, Caraci F, Nisticò R.   +6 more
europepmc   +1 more source

Immunological and Inflammatory Characteristics of Severe Cutaneous Adverse Drug Reactions: A Retrospective Study. [PDF]

Int J Gen Med
Luo Q, Mou XD, Cao D, Cheng WH.
europepmc   +1 more source

Evaluation of Adverse Drug Reactions at Hospital Besut: A 5-year Retrospective Study. [PDF]

J Res Pharm Pract
Shafie NA, Tahir NA, Fami MLA, Juraimi NRH, Azmi NAM, Rashid RA.   +5 more
europepmc   +1 more source

Leveraging Administrative Health Data to Capture Rare Adverse Drug Reactions: Identifying Pediatric Patients With Trimethoprim-Sulfamethoxazole Acute Respiratory Distress Syndrome. [PDF]

Pharmacol Res Perspect
Feldman K, Miller JO, Doane K, Loftis L, Antoon JW, Downes KJ, Goldman JL.   +6 more
europepmc   +1 more source

Magnitude, Preventability, and Determinants of Adverse Drug Reactions Among Hospitalized Obstetric Patients in Ethiopia: A Prospective Observational Study. [PDF]

Pharmacol Res Perspect
Tarekegn GY, Tsegaw E, Dagnew FN, Anberbr SS, Moges TA, Dagnew SB, Wondm SA, Zerihun TE, Kassaw AT, Mussie DA.   +9 more
europepmc   +1 more source